APA (7th ed.) Citation

RO, A., B, W., H, B., A, M., B, N., A, P., . . . A, B. (2025). TOP1 Mutations and Cross-Resistance to Antibody-Drug Conjugates in Patients with Metastatic Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 31(10), 1966. https://doi.org/10.1158/1078-0432.CCR-24-2771

Chicago Style (17th ed.) Citation

RO, Abelman, et al. "TOP1 Mutations and Cross-Resistance to Antibody-Drug Conjugates in Patients with Metastatic Breast Cancer." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 31, no. 10 (2025): 1966. https://doi.org/10.1158/1078-0432.CCR-24-2771.

MLA (9th ed.) Citation

RO, Abelman, et al. "TOP1 Mutations and Cross-Resistance to Antibody-Drug Conjugates in Patients with Metastatic Breast Cancer." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 31, no. 10, 2025, p. 1966, https://doi.org/10.1158/1078-0432.CCR-24-2771.